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To characterize the antigenicity of nucleocapsid proteins (NP) derived from canine coronavirus (CCoV) and canine respiratory 
coronavirus (CRCoV) in China, the N genes of CCoV (CCoV-BJ70) and CRCoV (CRCoV-BJ202) were cloned from swabs 
obtained from diseased pet dogs in Beijing and then sequenced. The recombinant NPs (rNPs) were expressed in Escherichia 
coli and purified by nickel-affinity column and size exclusion chromatography. Sequencing data indicated that the N genes of 
CCoV-BJ70 and CRCoV-BJ202 belonging to two distinctly different groups were relatively conserved within each subgroup. 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) results showed that rNPs of CCoV and CRCoV were 
expressed efficiently and isolated with a final purity of over 95%. Western blot analysis revealed the rNP from CRCoV could 
cross-react with mice antisera against human coronavirus (HCoV-229E, NL63, OC43, HKU1), while rNP of CCoV had 
cross-reactivity with only anti-sera against viruses belonging to the same group (HCoV-229E and NL63). In summary, CCoV 
and CRCoV rNPs were successfully expressed in E. coli and showed antigenic cross-reactivity with antisera raised against 
human coronaviruses. These findings indicate that further serologic studies on coronavirus infections at the animal-human in-
terface are needed. 
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Coronaviruses are enveloped, positive-stranded RNA virus-
es that are highly prevalent in animal and human popula-
tions (Woo et al., 2009). To our knowledge, six types of 
coronaviruses have been recognized to be pathogenic to 
humans: HCoV-NL63, HCoV-229E, HCoV-OC43, SARS- 
CoV, HCoV-HKU1 and MERS-CoV. Because of the high 
mutation frequency and broad host ranges of this virus, 
novel coronaviruses have emerged and evolved to cross 
species during the past decade, generating novel strains, 
serotypes and genotypes. Canine coronavirus (CCoV) and 
canine respiratory coronavirus (CRCoV) are common viral 
pathogens responsible for mild to severe enteritis or respir-
atory symptoms in dog populations (Nicola and Canio, 
2008). CCoV infection was first reported in a German mili-
tary dog with diarrhea in 1971 (Binn et al., 1974). Since 
then, CCoV has been determined to be epidemic globally, 
and dogs of all breeds and ages appear to be susceptible to 
infection (Costa et al., 2014; Erles and Brownlie, 2009; 
Lorusso et al., 2009; Naylor et al., 2002; Yachi and 
Mochizuki, 2006). In China, CCoV was isolated from the 
heart and gastrointestinal contents of a sick dog for the first 
time in 1995 (Kong, 2007), and identified in deceased giant 
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pandas in 2009 (Gao et al., 2009). In 2003, a novel respira-
tory coronavirus (CRCoV) distinct from CCoV was detect-
ed from the respiratory tracts of diseased dogs in the UK 
(Erles et al., 2003). Currently, CRCoV is found in dogs in 
Europe as well as Asia (Lorusso et al., 2009; Yachi and 
Mochizuki, 2006). 
Coronaviruses are classified phylogenetically into four 
genera: Alphacoronavirus, Betacoronavirus, Gammacoro-
navirus, and Deltacoronavirus. Alphacoronaviruses include 
human coronaviruses HCoV-229E and HCoV-NL63, por-
cine transmissible gastroenteritis virus (TGEV), feline 
coronavirus (FCoV), and CCoV. Four human coronaviruses 
HCoV-OC43, SARS-CoV, HCoV-HKU1, MERS-CoV and 
bovine coronavirus (BCoV), as well as CRCoV, are Be-
tacoronaviruses, but belong to different subgroups. Phylo-
genetically, CCoV is closely related to HCoV-229E and 
HCoV-NL63, while CRCoV is close to BCoV and 
HCoV-OC43. It has been suggested that CRCoV might 
share the same ancestor in this clade, or originated from a 
host transfer from bovine to canine (Erles et al., 2003). 
Coronavirus harbors the largest genome among the 
known RNA viruses, about 27–31 kb, mainly encoding for 
the structural proteins spike (S), envelope (E), membrane 
(M), and nucleocapsid (N), and several other open reading 
frames (ORFs) encoding non-structural proteins. As report-
ed, the glycosylated S protein mediates attachment of the 
coronavirus to cellular receptors and fusion with the cell 
membrane (Belouzard et al., 2012). The N protein is a 
phosphorylated protein, and is the most abundant. It inter-
acts with viral RNA and makes up the core structure of viral 
particles (Li et al., 2005). It has been revealed that a high 
level of IgG antibodies against the N protein of SARS-CoV 
can persist for a long time after the onset of symptoms, and 
thus may be a marker for highly sensitive serological diag-
nosis (Tan et al., 2004). As the N protein is an unglycosyl-
ated protein, it can be easily expressed in bacteria and iso-
lated with high purity. Therefore, antibodies against N pro-
tein appear to be ideal candidates as diagnostic markers. 
Due to the high homology among coronaviruses in the 
same subgroup, antisera from HCoV-NL63 (Alphacorona-
virus, subgroup 1b), HCoV-OC43 (Betacoronavirus, sub-
group 2a), SARS-CoV (Betacoronavirus, subgroup 2b) and 
MERS-CoV (Betacoronavirus, subgroup 2c)-infected hu-
mans recognize the N proteins of a particular subgroup but 
do not react with N proteins from other subgroups, as pre-
viously reported (Sudhakar et al., 2014). However, 
cross-reactivities have been found previously among dif-
ferent genera. Anti-CCoV sera reacted with the N protein of 
SARS-CoV, a Betacoronavirus (Sun and Meng, 2004; 
Vlasova et al., 2007). Furthermore, polyclonal antibodies 
from Alphacoronaviruses, including HCoV-229E, feline 
infectious peritonitis virus (FIPV), and TGEV, reacted with 
SARS-CoV infected Vero cells (Shi et al., 2003), demon-
strating conserved antigenic sites of N protein might exist 
among different genera. However, there is no data on the 
reactivity between CCoV or CRCoV N proteins and antisera 
derived from other human coronaviruses (such as HCoV- 
OC43, -NL63, -HKU1 and MERS-CoV).  
Considering the global spread of CCoV and CRCoV in-
fections among dog populations and the possible interspe-
cies transmission from animals to humans, it is necessary to 
develop rapid and accurate assays for early diagnosis and 
epidemic control. However, there are very limited studies 
on CCoV and CRCoV circulating in China, and the anti-
genic relationship among CCoV, CRCoV and human coro-
naviruses. Here, the N coding genes of CCoV and CRCoV 
in China were amplified and sequenced, and then the re-
combinant N proteins of CCoV and CRCoV were prepared 
and characterized. In addition, cross-reactivity was analyzed 
between the recombinant proteins and polyclonal mice an-
tisera from human coronaviruses. 
RESULTS 
Cloning and sequence analysis of NPs derived from 
CCoV and CRCoV in China  
The genes encoding the N proteins of CCoV and CRCoV 
were amplified and sequenced with the gene lengths being 
1,149 bp for CCoV-BJ70 and 1,347 bp for CRCoV-BJ202. 
Phylogenetic analysis showed that the CCoV N gene ob-
tained in this study had the closest relationship with CCoV- 
NTU336, an Alphacoronavirus strain isolated in Taiwan 
(Figure 1). Amino acid sequence alignment revealed the N 
gene of CCoV-BJ70 had a relatively high identity of 98.2% 
compared to CCoV-NTU336. In addition, the N gene of  
 
 
Figure 1  Phylogenetic relationship of coronaviruses based N gene. 
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CCoV-BJ70 was also 91.4% to 97.7% identical to other 
strains of canine coronaviruses, including CCoV-TN449, 
CCoV-1-71, CCoV-fc00-089, CCoV-GPV, CCoV-A76, 
CCoV-K378, CCoV-BGF10, and CCoV-INSAVC. Com-
pared with the closely related coronavirus strains from pig 
(TGEV-Purdue) and cat (FCoV-Black), the identity of 
amino acid sequence was 93.5% and 78.6% respectively 
(data not shown), showing the higher genetic relatedness 
between CCoV and TGEV. In order to determine the geno-
type of CCoV-BJ70, we amplified a partial sequence of the 
S gene and found that the genotype of CCoV-BJ70 be-
longed to CCoV-II (data unpublished). Comparison of the 
CRCoV-BJ202 N gene sequence to related CRCoV strains 
revealed that it was most similar to sequence data from 
BCoV-ENT, CRCoV-K37 and HCoV-OC43, which all be-
long to Betacoronavirus genus. The identity of the analyzed 
amino acid sequence was 98.4% to CRCoV-4182 and 
97.6% to CRCoV-K37 respectively (data not shown), fol-
lowed with the identity of 97.3% to BCoV-ENT and 96.7% 
to HCoV-OC43, while it was only 24.7% to CCoV-BJ70 
(Table 1).  
Furthermore, a highly conserved region (FYYLGTGP) 
was found through multiple alignments between the two N 
protein amino acid sequences to other five human corona-
viruses (Figure 2). The N of CCoV-BJ70 was closest to that 
of HCoV-NL63 with 39% identical residuals, whereas only 
24.5% to 27.0% with coronaviruses belonging to the Be-
tacoronavirus genus. In contrast, the homology of N pro-
teins between CRCoV-BJ202 and HCoV-OC43 can be up to 
96.7%, but only 26.9% and 24.2% to HCoV-229E and 
HCoV-NL63, respectively (Table 1). 
Expression and purification of the recombinant N 
proteins of CCoV and CRCoV 
Both recombinant NPs of CCoV and CRCoV were ex-
pressed in either soluble form or inclusion bodies, with ob-
vious bands at about 45 and 55 kD respectively, which cor-
responds to our prediction (Figure 3). Optimization of the 
expression conditions indicated that N proteins had the 
highest soluble expression level with induction at 37°C for 
4 h (data not shown). The soluble rNPs were purified by 
Ni2+ and S75 columns. SDS-PAGE showed the isolated 
CCoV-N and CRCoV-N both had a high purity of over 
95%. Meanwhile, Western blot analysis demonstrated reac-
tivity with His monoclonal antibody specifically at the cor-
responding sizes (Figure 4). 
Antigenic relationships between N proteins of CCoV, 
CRCoV and HCoVs 
Since the N proteins of coronaviruses are relatively con-
served, we aimed to determine whether the N protein was 
responsible for antigenic cross-reactivity. Western blot 
analysis showed that the CCoV N protein cross-reacted 
weakly with mice antisera against the NP of HCoV-NL63 
and 229E, indicating the N protein of CCoV may share the 
same antigenic epitopes with that of human alphacorona-
viruses. However, the CRCoV N protein can react strongly 
with mice polyclonal sera against NP of HCoV-HKU1, 
OC43, NL63 and 229E, while having no reactivity with that 
of MERS-CoV (Figure 5). 
DISCUSSION 
Since the emergence of the SARS-CoV in 2002, which was 
considered a zoonosis coronavirus transmitted from bats to 
humans (Peiris et al., 2003), more attention has been fo-
cused on the emerging and re-emerging viral pathogens in 
animals and humans. As viral pathogens commonly detect- 
ed in diseased dogs worldwide, CCoV and CRCoV are 
thought to be responsible for gastrointestinal inflammations  
Table 1  Identity analysis of N protein among coronavirus strains in this research 
Coronavirus CCoV-BJ70 HCoV-229E HCoV-NL63 HCoV-OC43 CRCoV-BJ202 HCoV-HKU1 MERS-CoV 
CCoV-BJ70 100% 38.1% 39.9% 24.5% 24.7% 25.9% 27.0% 
HCoV-229E  100% 48.8% 27.1% 26.9% 29.2% 25.7% 
HCoV-NL63   100% 24.8% 24.2% 25.6% 25.5% 
HCoV-OC43    100% 96.7% 65.8% 33.0% 
CRCoV-BJ202     100% 66.1% 33.0% 
HCoV-HKU1      100% 32.6% 
MERS-CoV       100% 
 
 
Figure 2  Sequence alignment of N protein from seven different coronavirus strains. The highly conserved sequence is indicated by a red frame. 
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Figure 3  SDS-PAGE analysis of the expression and purification of CCoV and CRCoV N proteins in E. coli. Lane M, marker. Lane 1, uninduced E. coli. 
Lane 2, induced by IPTG. Lane 3, supernatants of expression products. Lane 4, pellets of expression products. Lane 5, purified protein. 
 
Figure 4  Western blot analysis of recombinant proteins reacted with 
anti-His mouse monoclonal antibody. Lane M, marker. Lane 1, CCoV-NP. 
Lane 2, CRCoV-NP. 
and respiratory infections, and signs of infections vary from 
mild to moderate, but are severe in puppies or in combina-
tion with other pathogens (Kong, 2007). N protein is an 
abundant and crucial structural protein in coronavirus parti-
cles, and has an important role in the viral immune response 
(Li et al., 2005). Antigen-capture enzyme-linked immuno-
sorbent assays (ELISAs) using monoclonal antibodies 
against the N protein of SARS-CoV have been validated as 
useful for early diagnosis of SARS (Che et al., 2004). Thus, 
serological assays targeting the NP of coronaviruses are 
considered important to for diagnosis of viral infection. 
Characterization of the antigenicity of nucleocapsid proteins 
derived from individual coronaviruses is essential for the 
development of serological assays for coronaviruses. 
It is notable that CoVs are characterized as having high 
rates of mutation and recombination, which is important to 
the transfer of hosts and alterations of virulence. We cloned 
the NP coding genes of CCoV (CCoV-BJ70) and CRCoV 
(CRCoV-BJ202) from diseased pet dogs in Beijing and fol-
lowed with sequence analysis. Our data identified that 
CCoV-BJ70 and CRCoV-BJ202 belong to two distinctly 
different subgroups with close relationships with strains 
isolated from relatively near regions, based on the N gene 
phylogenetic tree. The CCoV-BJ70 clustered with other 
CCoVs in the Alphacoronavirus genus, including a Chinese 
strain isolated from deceased giant pandas, but was distinct 
from heterologous coronaviruses HCoV-229E and NL63. 
CRCoV-BJ202 was closely related to a Korean strain: 
CRCoV-K37, as well as HCoV-OC43. Furthermore, N pro-
tein identity between CCoVs and HCoVs also confirmed the 
phylogeny. Notably, the N protein identity observed be-
tween CCoV-BJ70 and HCoVs was only 25.5% to 39.9%, 
but was highly similar with other CCoV strains. However, 
CRCoV-BJ202 has a high identity of 96.7% to HCoV- 
OC43, suggesting that CRCoV might share the same origin 
with HCoV-OC43 or recombination has occurred between 
them. Although the phylogenic relationship and amino acid 
sequence similarity was observed, the potential of cross- 
reactivity between these coronaviruses is still unclear.  
In this study, we expressed the N proteins of CCoV and 
CRCoV for serological studies. To our knowledge, the 
cloning and sequencing of the NP of CRCoV was first re-
ported in China. Furthermore, we analyzed the antigenic 
relationship among CCoV, CRCoV and HCoVs. As shown 
in Figure 5, CCoV NP reacted with antisera from 
HCoV-229E and NL63 belonging to Alphacoronavirus, but 
showed weaker antigenicity, which may be due to the lim-
ited number of conserved antigenic sites among the sub-
group. No significant cross-reactivity was observed to poly-
clonal antisera from three other HCoVs in the Betacorona-
virus genus, indicating an extremely low avidity of the re-
spective antibody, or a distinctly far antigenic relationship 
between these different clades. In contrast, CRCoV NP 
showed cross-reactive binding to antisera from mice im-
munized with the N proteins of HCoV-HKU1 and OC43,  
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Figure 5  Western blot analysis of cross-reactivity of CCoV and CRCoV N proteins with mice antisera against NP of human coronaviruses.  
respectively, to a nearly same degree, and they all resolved 
into several fuzzy bands, except to the anti-MERS-CoV. 
Interestingly, CRCoV seems to be phylogenetically distant 
with HCoV-229E and NL63, but showed weaker reactivity 
than that of HCoV-HKU1 and OC43. This might be ex-
plained by conserved NP immune epitopes shared between 
both alpha and beta viruses, such as the highly conserved 
motif FYYLGTGP. In addition, CRCoV NP reacted 
strongly with anti-OC43 as did anti-HKU1, which may be 
attributed to the high identity of the NP amino acid se-
quence of CRCoV to HCoV-OC43 and HKU1 respectively. 
However, CRCoV NP showed weaker reactivity with an-
ti-MERS-CoV than antisera derived from four other 
HCoVs. This may be due to the variations in their primary 
sequence, which can influence the antigenic sites and lead 
to a variety of cross-reactivity. Furthermore, the cross-  
reactivity generated between the two rNPs and anti-HCoVs 
was inconsistent with the identity of the NP sequences. This 
difference is possibly due to insufficient recognition by 
HCoVs antibodies, or different antigenic sites within the N 
proteins were exposed to an immune response, also indicat-
ing the potential complexity in serological diagnosis.  
Our results revealed the presence of cross-reactive 
epitopes in the N proteins within a particular subgroup and 
also among different subgroups, and raised potential con-
cerns in serological assays based on N proteins, providing 
implications for further research on coronaviruses testing. 
Therefore, it is important to identify a type-specific immune 
reactive epitope to the N protein or other appropriate diag-
nostic markers against coronaviruses with no antigenic cross- 
reactivity for identification of the coronavirus infections. 
MATERIALS AND METHODS 
Swabs and antisera 
Swabs of positive CCoV and CRCoV (as determined by an 
antigen captured rapid diagnostic strip) were collected from 
diseased pet dogs visiting the veterinary hospital affiliated 
to the College of Veterinary Medicine, China Agricultural 
University. The anti-His monoclonal antibody was pur-
chased from ZSGB-Bio (China). Mice antisera against the 
individual NPs of HCoV-229E, NL63, OC43, and HKU1 
were kindly provided by Prof. Jianwei Wang and Li Guo 
(Chinese Academy of Medical Sciences). Mouse antisera 
against MERS-CoV were prepared in our lab. 
Cloning of the N genes from CCoV and CRCoV 
Viral RNA was obtained from 140 μL of clarified swab 
extract with a QIAamp Viral RNA mini kit (QIAGEN, 
Germany) following the manufacturer’s instructions. 
One-step RT-PCR (QIAGEN) was performed to amplify the 
full-length N genes of CCoV and CRCoV using specific 
primers with enzyme cleavage sites BamH I and Xho I (Ta-
ble 2). The PCR products were cloned into the pMD19-T 
vector and verified by sequencing. The nucleotide sequenc-
es obtained were deposited to GenBank under the accession 
numbers KT852997 & KT852998.  
Sequences of other related coronaviruses strains in this 
study were downloaded from GenBank (CCoV-171: 
KC175339; CCoV-INSAVC: D13096;CCoV-TN449: 
EF056485; CCoV-K378: KC175340; CCoV-GPV: 
AY436636; CCoV-BGF10: AY342160; CCoV-fc00-089: 
AB781805; CCoV-A76: JN856008; CCoV-NTU336: 
GQ477367; TGEV-Purdue: DQ811789; FCoV-Black: 
EU186072; BCoV-ENT: NC_003045; CRCoV-K37: 
JX860640; CRCoV-4182: DQ682406; HCoV-229E:NC_ 
002645; HCoV-NL63: NC_005831; HCoV-OC43: 
NC_005147; SARS-CoV: NC_004718; HCoV-HKU1: 
NC_006577; MERS-CoV: NC_019843; TCoV-MG10: 
NC_010800). Multiple sequence alignment was carried out 
using the ClustalW and MegAlign software. The phyloge-
netic tree was constructed by a neighbor-joining method 
using MEGA 6.0 software.
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Table 2  Primers for plasmids construction (enzyme cleavage site is underlined) 
Target gene Primer Nucleotides sequences(5′→3′) Restriction enzyme 
CCoV-N P1 CGCGGATCCATGGCCAACCAGGGACAAC BamH I 
CCoV-N P2 CCGCTCGAGTTAGTTCGTTACCTCATC Xho I 
CRCoV-N P3 CGCGGATCCATGTCTTTTACTCCTGG BamH I 
CRCoV-N P4 CCGCTCGAGTTATATTTCTGAGGTGTC Xho I 
 
Expression and purification of the recombinant N proteins 
Plasmids containing the N gene of CCoV and CRCoV were 
digested by the corresponding restriction enzymes and in-
serted into the bacterial expression vector pET28a (No-
vagen, Germany). All constructs were confirmed by enzyme 
digestion and DNA sequencing. The recombinant plasmids 
were transformed into expression E. coli competent cells 
BL21 (DE3). The E. coli culture was induced by adding 
isopropyl -D-1-thiogalactopyranoside (IPTG) at a final 
concentration ~0.5 mmol L1 and incubating at three differ-
ent conditions: 37°C for 4 h; 25°C for 10 h and 18°C for 16 
h. After induction, the bacterial cells were harvested and 
suspended in binding buffer (Tris, 50 mmol L1; NaCl, 500 
mmol L1; pH 8.0), and lysed by sonication for 20 min in an 
ice water bath, followed by centrifugation at 34,900×g for 
30 min at 4°C.The supernatants and pellets were collected 
separately, and analyzed by 12% SDS-PAGE. 
The recombinant NPs in the supernatant were purified 
using a nickel-affinity column using the AKTA system, and 
further processed by size exclusion chromatography (Su-
perdex 75 column, GE, USA). Briefly, the protein was 
eluted using different gradients of elution buffer (Tris, 50 
mmol L1; NaCl, 500 mmol L1; imidazole, 500 mmol L1; 
pH 8.0). The concentrated peak eluates were then subjected 
to an equilibrated S75 column and the purified soluble re-
combinant NPs were analyzed by SDS-PAGE. 
Antigenic analysis of the recombinant N proteins 
The purified rNPs of CCoV or CRCoV separated by elec-
trophoresis on the gels were transferred to nitrocellulose 
membrane, followed by blocking in 5% skim milk in phos-
phate buffer saline (PBS) at room temperature for 2 h. Af-
terwards, the blots were washed and incubated with anti-His 
monoclonal antibody (1:1,000 dilution) and mice antisera 
against HCoV-229E, NL63, OC43, HKU1 and MERS-CoV 
(1:200 dilution) separately at 4°C overnight. After three 
washes, goat anti-mouse IgG conjugated with HRP 
(1:5,000 dilution, ZSGB-Bio) or IRDye anti-mouse IgG 
(1:5,000 dilution, Odyssey) was added respectively and 
incubated at room temperature for 2 h. The membrane was 
thoroughly washed and then developed with the substrate 
DAB or using the OdysseyTM infrared imaging system. 
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